X4 Pharmaceuticals, Inc. ( XFOR) - Stock Earnings
XFOR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
XFOR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -23.9 million USD | 2.6 million USD |
| 2026Q1 | -20.2 million USD | 2.7 million USD |
| 2026Q2 | -16.2 million USD | 8.8 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
XFOR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -101.2 million USD | — USD |
| 2024 | -37.5 million USD | 2.6 million USD |
| 2025 | -79.2 million USD | 35.1 million USD |
| 2026 Est. | — | — |
XFOR
Price: $2.59
Earnings Per Share: 1.43 USD
P/E Ratio: 3
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 471700
Market Capitalization: 266.9 million